With over €47,000 on the counter, Kiemeney can see the Tour de France as a great success. Not only did he get close to his target amount (you can still donate!), but Bart was also one of the few to have covered the entire course of this edition of the Tour de France.
"Now I'm really not going to cycle the Tour anymore!” the professor writes in his epilogue.
Bart's Tour de France
Read the entire epilogue on www.tourdefrancevanbart.nl or donate.That's still possible!
-
Want to know more about these subjects? Click on the buttons below for more news.
RIHSHealth EvidenceHealthcare improvement scienceUrology ResearchRare cancersTumors of the digestive tract Urological cancersWomen's cancers
Related news items
Dutch Cancer Society Grant received by Annemiek van Spriel and Laia Querol-Cano
23 September 2020Annemiek van Spriel and Laia Querol-Cano received a Dutch Cancer Society Grant of 700K euros to study the cancer cell surface in immunotherapy.
read more
Tumor cells stimulate lipid biosynthesis in macrophages
23 September 2020RIMLS researchers wrote in the Journal for ImmunoTherapy of Cancer that improved lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics.
read more
Frank Walboomers 25-years work anniversary at Radboudumc
17 September 2020Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.
read more
Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes
17 September 2020Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.
read more
Annette Schenck appointed professor of Translational Genomics of Neurodevelopmental Disorders
17 September 2020Annette Schenck has been appointed professor of Translational Genomics of Neurodevelopmental Disorders. with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.
read more
Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients
17 September 2020Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.
read more